Athena Athena

X

Digital content for HemoShear Therapeutics

  • Webinars & Exhibitions

PharmaCompass
Send me more info on How To Grow My Bussiness Digitally?
HemoShear Therapeutics
United_States_of_America Flag
Country
Country
U.S.A
Address
Address
501 Locust Avenue Suite 301 Charlottesville, Virginia 22902
Telephone
Telephone

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

https://www.prnewswire.com/news-releases/hemoshear-therapeutics-to-participate-in-svb-leerink-securities-biopharma-private-company-connect-301650935.html

PRNEWSWIRE
18 Oct 2022

https://www.prnewswire.com/news-releases/hemoshear-develops-new-human-tissue-based-model-of-rare-liver-disease-under-research-collaboration-with-takeda-301602822.html

PR NEWSWIRE
10 Aug 2022

https://www.prnewswire.com/news-releases/hemoshear-therapeutics-identifies-second-novel-target-to-treat-nash-through-successful-collaboration-with-takeda-301424799.html

PRNEWSWIRE
16 Nov 2021

https://www.prnewswire.com/news-releases/hemoshear-therapeutics-advancing-several-novel-compounds-for-horizon-therapeutics-plc-gout-discovery-pipeline-301380995.html

PRNEWSWIRE
21 Sep 2021

https://www.biospace.com/article/releases/hemoshear-therapeutics-raises-40-million-in-series-a-financing-to-advance-rare-disease-portfolio/

BIOSPACE
10 Feb 2021

https://www.prnewswire.com/news-releases/hemoshear-therapeutics-hst5040-receives-us-orphan-drug-designations-for-treatment-of-methylmalonic-acidemia-and-propionic-acidemia-301193648.html

PRNEWSWIRE
16 Dec 2020

https://www.prnewswire.com/news-releases/hemoshear-therapeutics-identifies-novel-drug-target-to-treat-nash-in-drug-discovery-partnership-with-takeda-301189996.html

PRNEWSWIRE
10 Dec 2020

https://www.prnewswire.com/news-releases/hemoshear-therapeutics-enters-into-rare-liver-disease-research-collaboration-with-takeda-301157045.html

PRNEWSWIRE
21 Oct 2020

https://www.prnewswire.com/news-releases/hemoshear-therapeutics-receives-fda-fast-track-and-rare-pediatric-disease-designations-for-hst5040-to-treat-methylmalonic-acidemia-and-propionic-acidemia-301100714.html

PRNEWSWIRE
28 Jul 2020

https://www.prnewswire.com/news-releases/hemoshear-therapeutics-receives-fda-fast-track-and-rare-pediatric-disease-designations-for-hst5040-to-treat-methylmalonic-acidemia-and-propionic-acidemia-301100714.html

PRNEWSWIRE
27 Jul 2020
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY